rqmicro.com Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • rqmicro.com's estimated annual revenue is currently $2.6M per year.(i)
  • rqmicro.com's estimated revenue per employee is $155,000

Employee Data

  • rqmicro.com has 17 Employees.(i)
  • rqmicro.com grew their employee count by 6% last year.

rqmicro.com's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$81.4M37540%N/AN/A
#2
$16.9M10922%N/AN/A
#3
$156.1M120-70%$145MN/A
#4
$2.9M37-24%$150MN/A
#5
$1.3M170%$459.5MN/A
#6
$49.2M25415%$180.7MN/A
#7
$7M45-2%N/AN/A
#8
$256.3M8409%$168.5MN/A
#9
$4.2M27-7%N/AN/A
#10
$10.1M655%N/AN/A
Add Company

What Is rqmicro.com?

rqmicro AG, based in Zurich, Switzerland, develops and markets proprietary reagents and innovative instruments for rapid microbiological tests for water and food safety. The new separation and detection technology is based on immunomagnetic separation and microfluidics and delivers accurate results at an unmatched speed. Common methods in microbiology need up to 14 days to give you semi-quantitative data. A waiting time that takes time and money. rqmicro reduces this delay significantly by providing precise quantitative results. With rqmicro instruments you can quantify Legionella in water samples in 1-2 hours.

keywords:N/A

N/A

Total Funding

17

Number of Employees

$2.6M

Revenue (est)

6%

Employee Growth %

N/A

Valuation

N/A

Accelerator

rqmicro.com News

2022-04-17 - Rapid Microbiology Testing Market Overview, Size, Trend and ...

Rqmicro AG (Switzerland). Bactest Ltd. (US). Colifast (Norway). Serosep Ltd. (Ireland). Biosensia (Ireland). Solus Scientific Solutions Ltd.

2022-04-13 - Global Flow Cytometry Services Market Report 2022-2035 ...

... rqmicro; Saltro (Acquired by Unilabs); Sartorius Stedim Biotech; SBT Instruments; Sirigen (Acquired by BD); Sony Biotechnology...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$1.4M176%N/A
#2
$2.6M17-6%N/A
#3
$1.5M17-11%N/A
#4
$1.7M17N/AN/A
#5
$1.7M17-69%N/A